Sarkissian Vahé
Department of Neurological Surgery, University of California at San Francisco, 513 Parnassus Ave., San Francisco, CA 94143, USA.
Neurosci Lett. 2005;382(1-2):118-23. doi: 10.1016/j.neulet.2005.02.068. Epub 2005 Apr 19.
Cranial irradiation (CI) confers remediation of many CNS anomalies. CI, however, carries risks to cognitive performance. A wealth of data describes such deficits specifically in humans. Risk factors that promote increased susceptibility to cognitive decline have also been identified. This paper discusses and grades these risk factors, including age, gender, and the inclusion of chemotherapy, that increase the likelihood of pathologic cognitive development in the human population.